[The effect of allapinine on external respiratory function in patients with diseases of the cardiovascular system].
The cardiorespiratory system was studied comprehensively in 27 patients with permanent atrial fibrillation (PAF) without the clinically marked signs of circulatory failure. After allapinine treatment 15 patients with bronchial obstruction manifestations demonstrated, in the presence of lasting PAF, a significant increase of the forced expiration capacity per s and of the maximum volumetric expiration rates. The data obtained may attest to the fact that the drug has beta-stimulating properties, confirming the reported evidence.
Smetnev
A S
AS
Kadyrova
M M
MM
Sobol'
Iu S
IuS
Sokolov
S F
SF
Kassirskiĭ
S G
SG
D000157:Aconitine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D012119:Respiration / Q000187:drug effects*; D012129:Respiratory Function Tests
D000889:Anti-Arrhythmia Agents; D001993:Bronchodilator Agents; C051402:allapinin; D000157:Aconitine
Izuchenie vliianiia allapinina na funktsiiu vneshnego dykhaniia u bol'nykh s zabolevaniiami serdechno-sosudistoĭ sistemy.